Estrella Immunopharma, Inc. (ESLA) Estimates

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Revenue Estimates

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26
Reported (Actual) 0.000.000.000.00----
High Estimate --0.000.000.000.000.000.00
Low Estimate --0.000.000.000.000.000.00
Consensus Estimate --0.000.000.000.000.000.00

Earnings Per Share (EPS) Estimates

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26
Reported (Actual) -0.12-0.12-0.07-0.07-0.19----
High Estimate --0.12-0.11-0.08-0.19-0.20-0.13-0.14-0.14
Low Estimate --0.12-0.09-0.06-0.17-0.18-0.11-0.12-0.12
Consensus Estimate --0.12-0.10-0.07-0.18-0.19-0.12-0.13-0.13